News Daily News Reductions in Stroke Observed With BP Less Than 140 mm Hg, Fueling Support for Lower Threshold Michael O'Riordan February 02, 2016
News Daily News Menos ACV con Presiones Arteriales Menor que 140 mm Hg Animan a Rebajar los Umbrales Michael O'Riordan February 02, 2016
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for January 2016 Shelley Wood February 01, 2016
News Daily News In the Real World, Dabigatran and Warfarin Give Equal Stroke Protection to A-fib Patients Todd Neale January 25, 2016
Presentation Sleep Fragmentation, Cerebral Arteriolosclerosis, and Brain Infarct Pathology in Older People Presenter: A.S.P. Lim January 13, 2016
News Features Possible Turf War Brewing Over Delivery of Acute Stroke Interventions Todd Neale December 28, 2015
Presentation Risk of Adverse Cardiac and Bleeding Events Following Surgery in Patients With Stents Presenter: Francesco Saia December 07, 2015
News Daily News Surgery Common in Stented Patients But Newer Stents Appear to Reduce Potential Risks Michael O'Riordan December 07, 2015
News Daily News Post-PCI Neurological Events, Though Infrequent, Continue to Carry ‘Abysmal’ Consequences Todd Neale November 22, 2015
News Daily News Los Episodios Neurológicos Post-PCI aunque Poco Frecuentes siguen Acarreando Consecuencias ‘Abismales’ Todd Neale November 22, 2015
News Industry News First Patient Successfully Enrolled into ROADSTER 2 Transcarotid Artery Revascularization (TCAR) Study November 02, 2015
News Industry News Medtronic Receives CE Mark for New Single-Chamber ICDs That Can Detect Atrial Fibrillation October 21, 2015
News Conference News TCT 2015 RESPECT Confirms Long-term Safety, Efficacy of PFO Closure for Recurrent Stroke Nicole Lou October 15, 2015
News Industry News Long-Term Study Results Show That PFO Closure May Be Effective In Preventing Recurrent Cryptogenic Stroke, Particularly In Younger Patients October 15, 2015
News Industry News CHMP grants positive opinion for idarucizumab, the specific reversal agent for dabigatran etexilate (Pradaxa®) September 25, 2015
News Industry News Jardiance® (empagliflozin) is the only diabetes medication to show a significant reduction in both cardiovascular risk and cardiovascular death in a dedicated outcome trial September 18, 2015
News Industry News US FDA Approves Expanded Indication For Brilinta To Include Long-term Use In Patients With a History of Heart Attack September 03, 2015
News Conference News ESC 2015 Prehospital Administration of Ticagrelor Cuts Early Ischemic Events in STEMI Patients L.A. McKeown September 01, 2015